Overview

Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Multicenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Vasoconstrictor Agents